{"id":"W4408780557","doi":"10.1016/j.ygyno.2025.03.022","title":"Comparative efficacy and safety of low-dose versus high-dose bevacizumab in ovarian cancer: An indirect treatment comparison","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Bevacizumab; Ovarian cancer; Oncology; Internal medicine; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01297526,0.002075139,0.00836929,0.001830481,0.000319829,0.002464281,0.001361552,0.002873692,0.007311445],"category_scores_gemma":[0.03078108,0.0008842014,0.01523195,0.001605974,0.001168284,0.001972013,0.001115886,0.003041063,0.0005509933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002019014,"about_ca_system_score_gemma":0.001206597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001026892,"about_ca_topic_score_gemma":0.001764854,"domain_scores_codex":[0.9800569,0.01467471,0.002416706,0.001152676,0.001452352,0.0002466538],"domain_scores_gemma":[0.973667,0.01932862,0.004892906,0.0007165566,0.0009622779,0.0004326251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.4866921,0.000971436,0.003114987,0.1125807,0.356668,0.0001324197,0.0002382268,0.00130943,0.0009514656,0.0009996447,0.0007600082,0.03558161],"study_design_scores_gemma":[0.4475743,0.05531304,0.01188021,0.01220782,0.4610391,0.0003403808,0.0002584952,0.00252342,0.001538456,0.002987188,0.004190519,0.0001470416],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3879194,0.5842521,0.005154713,0.001266193,0.003582941,0.0069378,0.003169019,0.0001462603,0.007571534],"genre_scores_gemma":[0.9399623,0.04687147,0.004116634,0.001052987,0.0007670749,0.004753356,0.001061934,0.00002995791,0.001384185],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01297526,"threshold_uncertainty_score":0.06862056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1088116024330933,"score_gpt":0.4425460591949762,"score_spread":0.333734456761883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}